Sectors
The deal, valued at up to $14bn, has fallen through after SoftBank failed to secure the backing of enough Intelsat creditors.
Microsoft has purchased the cybersecurity company, backed by Hewlett Packard, for $100m.
Online identity verification platform Are You A Human has been acquired by Distil Networks, allowing corporate venturing unit MDC Dream Ventures to exit.
Bioverativ could end up paying $825m for rare disease drug developer True North, which had raised $142m from backers including GlaxoSmithKline, Biogen Idec, Baxter and Baxalta.
Wells Fargo has exited alternative investments analysis platform AltX in an acquisition by financial software producer Addepar.
WuXi PharmaTech's corporate venturing arm will merge with VC firm Frontline BioVentures to create an investment firm with $800m of assets under management.
The enterprise software company has invested an undisclosed sum in automated HR app creator BuildOnMe and acquired another artificial intelligence tool developer, Qlue.
VMware has acquired one of its portfolio companies, app performance management platform Apteligent, in a deal that also gave exits to Alphabet, AOL and Accenture.
The reverse merger with Nasdaq-listed Mirna, which counts Pfizer and Baxter as backers, was agreed alongside the disclosure of a $42m series C round.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
